Strategic Report on Anti-Inflammatory Therapeutics Market: Growth Opportunities and Emerging Challenges
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Will the Anti-Inflammatory Therapeutics Market Evolve in Terms of Growth and Size by 2029?
The growth of the anti-inflammatory therapeutics market has been consistent over the past few years. It is projected to surge from $114.71 billion in 2024 to $117.28 billion in 2025, with a compound annual growth rate (CAGR) of 2.2%. Factors such as the widespread occurrence of chronic diseases, an aging population, heightened awareness, and government policies have contributed to this growth during the historic period.
In the forthcoming years, the market for anti-inflammatory therapeutics is projected to experience a consistent growth. The market is set to expand to “$142.15 billion by 2029, with a compound annual growth rate (CAGR) of 4.9%. Factors contributing to the projected growth during this prediction period include the development of innovative therapies, rise in healthcare expenditure, emphasis on rare diseases, and the introduction of biologics and biosimilars. Upcoming trends within this predicted timeframe encompass advancements in immunotherapies, the application of artificial intelligence (AI) and machine learning (ML) in drug discovery processes, and broadening of indications.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp
What factors are expected to fuel Anti-Inflammatory Therapeutics market growth in the coming years?
The growth of the anti-inflammatory therapeutics market is predicted to be fueled by the rising prevalence of inflammatory bowel disease. Characterized by chronic inflammation of the gastrointestinal tract, inflammatory bowel disease (IBD) is a persistent health condition. In the management of Crohn’s disease, anti-inflammatory therapeutics are significant as they mitigate inflammation, control disease symptoms, and lower the likelihood of surgical intervention. A July 2023 report from the Oxford University Press (OUP), the publication body of the University of Oxford, recorded IBD incidence at 10.9 per 100,000 person-years and prevalence at 721 per 100,000 individuals. Therefore, this rise in inflammatory bowel disease prevalence is triggering the expansion of the anti-inflammatory therapeutics market.
The anti-inflammatory therapeutics market covered in this report is segmented –
1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics
2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution
Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen
2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone
3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins
What Upcoming Trends Are Expected To Impact The Anti-Inflammatory Therapeutics Market Globally?
Key players in the anti-inflammatory therapeutics industry are creating pioneering drugs to fortify their market standing. For example, Regeneron Pharmaceuticals Inc., an American biotech firm, together with Sanofi, a French pharmaceutical and healthcare company, introduced Kevzara (sarilumab) in February 2023. This is the first and only anti-inflammatory biologic recommended for adult patients with PMR, an inflammatory rheumatic disease, who either do not have a proper response to corticosteroids or are unable to tolerate corticosteroid tapering.
What Are The Most Active Companies In The Anti-Inflammatory Therapeutics Market Today?
Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.
Which Regional Markets Are Attracting The Most Investment In Anti-Inflammatory Therapeutics?
North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
